ClinicalTrials.Veeva

Menu

Maternal and Neonatal Benefits of Prophylactic Administration of Vitamin K Before Elective Cesarean Section

N

National Research Centre, Egypt

Status

Completed

Conditions

Vitamin K

Treatments

Dietary Supplement: vitamin k

Study type

Interventional

Funder types

Other

Identifiers

NCT04984083
Prophylactic Vitamin K

Details and patient eligibility

About

Vitamin K deficiency can cause serious risks to pregnant women and their babies that may lead to hemorrhage, especially in newborns. We aim to evaluate the efficacy of vitamin k in decreasing blood loss during and after elective cesarean section (CS), and to assess the neonatal beneficial effects of prophylactic maternal vitamin k administration.

Enrollment

200 patients

Sex

Female

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age from 20-40 years.
  2. Gestational age between 36-39 weeks.
  3. Patients who will undergo an elective cesarean section.
  4. Full-term alive baby.
  5. Non-scarred uterus.
  6. No obstetric or medical complications.
  7. No bleeding tendency.

Exclusion criteria

  1. Patients at less than 36 gestational weeks.
  2. Patient refusal.
  3. Patients who have thrombo-embolic complications.
  4. Patients with obstetric and medical complications.
  5. Patients with anomalous fetuses.
  6. Patients on anti-coagulant drugs, long-term antibiotics, and anti-epileptic drugs.
  7. Patients with obstetric cholestasis.
  8. Patients with a previous history of preterm labor.
  9. Patients with multiple pregnancies.
  10. Gestational hypertension or preeclampsia.
  11. Blood clotting disorders.
  12. Placental abnormalities such as, Placenta accreta, Placenta increta, and Placenta percreta.
  13. Placental abruption and Placenta previa.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

200 participants in 2 patient groups

Group I
Experimental group
Description:
patients will take vitamin k 10 mg/ml once daily orally or IM between four and 96 hours before elective cesarean section
Treatment:
Dietary Supplement: vitamin k
Group II
No Intervention group
Description:
patients will not take vitamin k before cesarean section

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems